Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
12/06/2017 12/07/2017 12/10/2017 12/11/2017 12/12/2017 Date
5170(c) 5207(c) 5600(c) 5760(c) 5804 Last
1 318 184 7 180 278 1 198 198 2 094 998 251 554 Volume
-2.08% +0.72% +7.55% +2.86% +0.76% Change
More quotes
Financials ($)
Sales 2017 22 633 M
EBIT 2017 6 276 M
Net income 2017 -
Debt 2017 34 419 M
Yield 2017 -
Sales 2018 20 650 M
EBIT 2018 5 056 M
Net income 2018 -
Debt 2018 27 811 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,25x
EV / Sales2018 2,15x
Capitalization 16 590 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions.It operates through two segments: Generic Medicines and Specialty Medicines.The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines... 
Sector
Pharmaceuticals
Calendar
02/08Earnings Release
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
12/11 EXCLUSIVE : Teva to fire 500 managers in Israel
12/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra® T..
12/11 TEVA PHARMACEUTICAL INDUSTRIES : Announces Exclusive Launch of Generic Viagra® T..
12/10 TEVA PHARMACEUTICAL INDUSTRIES : mulls 10,000 layoffs - report
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08 TEVA CONSIDERING CUTTING UP TO 10,00 : Bloomberg
12/08DJTEVA PHARMACEUTICAL INDUSTRIES : May Cut Up to 10,000 Jobs -Bloomberg
12/07 TEVA PHARMACEUTICAL INDUSTRIES : Researchers Submit Patent Application, "Treatme..
12/04 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Today’s Research Reports on Trending Tick..
11/30 TEVA PHARMACEUTICAL INDUSTRIES : Report Summarizes Copaxone Therapy Study Findin..
More news
Sector news : Pharmaceuticals - NEC
08:42aDJGLAXOSMITHKLINE : Encouraged By Blood-Cancer Drug Study
07:32aDJSANOFI : Receives U.S. FDA Approval for Insulin Injection Admelog
12:56a Monsanto offers cash to U.S. farmers who use controversial chemical
12/11 ASTRAZENECA : GSK's new pharma head on lookout for cancer deals to boost pipelin..
12/11DJSANOFI : Urges Philippines to Lift Dengue Vaccine Suspension -AFP
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
12/11 FDA accepts Lilly's marketing application for migraine med galcanezumab
12/11 TEVA : Is This What A Bloodbath Looks Like?
12/11 BIOTECH ANALYSIS CENTRAL PHARMA NEWS : Sage's Depression Results, Pfizer's Viagr..
12/08 Teva may cut as many as 10K jobs; shares up 6%
12/05 TEVA PHARMACEUTICAL : A Holiday Season Sale
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 24,5 $
Spread / Average Target 50%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Michael R. Hayden Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-59.51%16 590
JOHNSON & JOHNSON21.23%377 698
NOVARTIS11.34%218 728
PFIZER9.48%213 036
ROCHE HOLDING LTD.6.19%208 877
MERCK AND COMPANY-7.68%151 559